GP Flashcards
(248 cards)
What are some of the causes of secondary hypertension?
Chronic Renal disease (Polycystic kidneys, diabetic glomerulosclerosis, glomerulonephritis)
Vascular - Renal artery stenosis and coarctation of aorta
Endocrine - Adrenal tumours secreting aldosterone, cortisol, ACTH, catecholamines (pheochromocytoma); cushing’s
Sleep apnoea
Meds (steroids, high oestrogen states such as OCP, HRT, pregnancy)
NOT atherosclerosis (except in case of renal artery stenosis)
How is the treatment protocol (pharm vs lifestyle modification) for different categories for HTN divided up?
Stage 1 SBP 140-179 ; DBP 90-109 with NO CV RFs: life style modification (pharm treatment if still high after 6 months)
Stage 1 SBP 140-179 ; DBP 90-109 WITH CV RFs or end-organ damage: start pharmacological treatment
Severe HTN SBP>180 ; DBP>110: start pharmacological treatment
Pharm. treatment (order of use) for HTN
Step 1:
If <55yo, ACE inhibitor (or AT1Rantag)
If >55yo or afro-carribbean origin - Ca channel blocker
if >65yo - low dose thiazide
Step 2:
ACE inhibitor + Ca channel blocker
Step 3:
Add thiazide diuretic (or beta blocker only if patient has IHD and heart failure)
If BP still elevated after step 3 = RESISTANT HTN
Step 4: Refer. Consider further diuretic (thiazide-like or spironolactone) or beta or alpha blocker
What drug combinations to avoid in HTN and why? (3)
- Ace inhibitor + K-sparing diuretic (spironolactone) - risk of hyperkalaemia
- Ca channel blocker + beta blocker - risk of heart block
- ACEi + AT1R antag - not shown to be clinically effective
LONG-TERM Treatment protocol for CHF
- Lifestyle modification
Smoking and alcohol cessation
Na and fluid restriction
Diet and exercise (weight control) - Treat underlying cause and aggravating factors (valvular disease/arrhythmia; thyroid, infection, anaemia, HTN)
- Meds
ACE inhibitor/ARB (slows progression, improves survival)
+ Beta blocker (slows progression, improves survival)
+/- aldosterone antag*(spironolactone) if severe and symptomatic
+/- diuretic (furosemide) if fluid overloaded
+/- digoxin (SX control only)
+/- antiarrhythmic (if AF)
+/- Warfarin (if AF, prior TE or LV thrombus on echo)
*mortality benefit
Precipitants/exacerbaters of heart failure
MADHATTER: MI/ischaemia Anaemia Drugs (NSAIDs, steroids, non-compliance) HTN Arrhythmias Thyroid Toxic (infection) Endocarditis/embolus Renal failure
Stable angina vs unstable angina
Stable:
- pain comes on w exercise, cold, stress and is relieved by stress. REPRODUCIBLE.
- due to atherosclerotic narrowing
Unstable:
- new onset pain or pain at rest
- accelerating pattern of pain
- pain post MI or post-procedure
- due to acute plaque event (plaque rupture, acute thrombus formation, partially occludes vessel)
STEMI vs non-STEMI
STEMI: Criteria for MI + ST elevation or new BBB
NON-STEMI: Criteria for MI WITHOUT ST elevation or new BBB
Criteria for MI
2 of the following:
- Classic SX of MI
- Elevated troponin, CK
- Typical ECG pattern (ST segment changes, T wave changes, new BBB, development of Q waves)
Long-term management of IHD post-acute ACS event (8)
- Dual anti-platelets (aspirin + clopidogrel)
- Beta blockers (Ca channel blocker second line)
- ACE inhibitors (prevent remodelling)
- Nitrates (GTN) PRN for symptom relief
- Statin (irrespective of cholesterol levels for plaque stabilisation)
- Modify lifestyle (exercise, diet, cease smoking, weight control, alcohol, stress)
- Modify CV Risk Factors (diabetes, cholesterol, HTN)
- Review (1 month then 6 mo thereafter)
Standard Management of dyslipidaemia
Manage modifiable risk factors
- Smoking cessation
- Diet (reduce saturated fats and refined sugars, incr fruit veg and fibre)
- Reduce alcohol
- 150min mod-intense exercise/week
- Weight reduction
Medications
- Statins are 1st line mono therapy
- If severe, add Fibrates +/- fish oil
Monitoring
- Monitor LFTs and CK at baseline then 6 weeks after starting statin (SEs)
- Fasting lipids at 3 mo, and if under control, monitor every 6-12 months thereafter.
What is the screening protocol for hyperlipidameia?
Full fasting lipid profile every 3 years for
○ Males > 40
○ Females > 50 (or menopausal)
○ Anyone with other CAD risk factors
Risk factors for AF
CHADS2
CCF HTN Age >75 DM Stroke/TIA/Thromboembolus previously
Management of CHRONIC AF
- Evaluate stroke risk and manage -> score 0 gets aspirin; score >1 gets anticoagulation (warfarin or NOAC)
- Rate control if patient stable (beta blocker, diltiazem, verapamil or digoxin, or amiodarone last line)
Rhythm control (SOTOLOL. flecainide»_space;> amiodarone if in HF) if patient is symptomatic or younger or has CCF
Triggers of AF
Heart failure/ischaemia HTN MI PE Valvular disease (mitral) Hyperthyroid Caffeine/alcohol
Management of Acute AF (<48 hours)
If very ill or haemodynamically unstable:
- O2
- Emergency cardioversion (electrical or IV amiodarone if unavailable. Flecanide)
- Rate control (Verapamil or Bisoprolol = Ca channel or beta blocker; digoxin or amiodarone 2nd line)
- Anticoagulation (LMWH)
Treat any triggering illnesses (pneumonia, MI, PE etc)
Sx and signs of PAD?
SX:
Claudication
Rest pain
Signs: Rubor Ulcers, gangrene, cellulitis Abnormal nails Shiny, hairless, cool/pale Decr pulses
Management of intermittent claudication
Lifestyle modification w intermittent claudication:
○ Diet and lifestyle
○ BP control (ACEi)
○ Aspirin
○ Statins
○ Smoking cessation
○ Exercise (improves fitness and general pump function as well as efficiency with using O2 delivered (if they stop walking to ‘control symptoms’ they will lose their legs)
Surgical mx w rest pain:
§ End-arterectomy for short segments
§ Angioplasty and stenting for short segments
§ Bypass for longer blocks
§ Amputation or palliation if unfit for surgery
Clinical presentation of chronic venous disease
Hyperpigmentation and haemosiderin staining
Brawny pitting OEDEMA
Lipodermatosclerosis
Varicose veins
Ulcers
Leg heaviness, ache and fatigue at end of day
Venous eczema: Pruritis, pain, swelling, erythema, recurrent cellulitis
LEg elevation, compression alleviates pain
What is venous disease caused by?
Venous HTN and venous insufficiency
causes of venous HTN (=OLD AGE)
- inadequate muscle pump function
- incompetent venous valves -> reflux
- venous thrombus or obstruction
Venous HTN leads to vein dilatation, skin changes and or ulceration
Treatment of peripheral venous disease
Initial conservative
§ Leg elevation - improves O2 delivery and reduces oedema
§ Compression - compresses dilated veins and reduces oedema; helps heal ulcers
§ Exercise - improves O2 delivery
§ Topical dermatological agents for stasis dermatitis
Vein ablation - surgical excision, sclerotherapy, thermal ablation
§ Requires a minimum of 3 months conservative therapy before proceeding w ablation.
Venous reconstruction (translocation of vein segments, transplantation of vein segments, substitution)
Treatment varicose veins
Compression stockings Leg elevation Injection sclerotherapy Surgery - vein removal (Stripping, ligation) Vein ablation
Characteristics of venous ulcers
Commonly found in gaiter region - medial aspect of calf/ankle
Large, flat/shallow
Irregular edges
Granulomatous base (pink/beefy red)
Mild pain
Pedal pulses present
Characteristics of arterial ulcers
VERY PAINFUL
Often on foot pressure point areas
Small size
Deep with punched out appearance
Regular margins
Sloughy/necrotic base
Absent pedal pulses